SECOND AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT between REGULUS THERAPEUTICS INC. And SANOFICollaboration and License Agreement • February 28th, 2014 • Regulus Therapeutics Inc. • Pharmaceutical preparations • New York
THIS SECOND AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is made and entered into this February 4, 2014 (the “Second Restatement Date”), by and between SANOFI (formerly, SANOFI-AVENTIS), a French Corporation (“Sanofi”) having a place of business at 54, rue la Boétie, 75008, Paris, France, registered in the Paris Trade and Company Register under no. 395 030 844, and REGULUS THERAPEUTICS INC., a Delaware Corporation (“Regulus”) having a place of business at 3545 John Hopkins Court, Suite 210, San Diego, California 92121-1121. Sanofi and Regulus each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
